Tumor therapy by gene regulation system responding to cellular signal

Journal of Controlled Release

Volumn 148, Issue 1, 2010, Pages 101-105

  Tomiyama, Tetsuro ^a   Toita, Riki ^a   Kang, Jeong Hun ^a,b   Asai, Daisuke ^c   Shiosaki, Shujiro ^a   Mori, Takeshi ^a   Niidome, Takuro ^a   Katayama, Yoshiki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene therapy; Intracellular signal; Peptide; Phosphorylation; Protein kinase

Indexed keywords

CASPASES; CATIONIC PEPTIDES; CELLULAR SIGNALS; GANCICLOVIR; GENE COMPLEXES; GENE DELIVERY; GENE DELIVERY SYSTEMS; GENE REGULATIONS; HERPES SIMPLEX VIRUS; INTRACELLULAR SIGNALS; INTRAPERITONEALLY; NEGATIVE CONTROL; PEPTIDE SIDE CHAINS; PHOSPHORYLATION SITES; POLYACRY LAMIDE; POLYMERIC CARRIERS; PRODRUGS; PROTEIN KINASE; PROTEIN KINASE C; SERINE RESIDUES; THERAPEUTIC GENES; THYMIDINE KINASE; TRANS-GENES; TUMOR CELLS; TUMOR GENE THERAPY; TUMOR GROWTH; TUMOR THERAPY;

AMINO ACIDS; GENE EXPRESSION; GENE TRANSFER; HISTOLOGY; PEPTIDES; PHOSPHORYLATION; POLYMERS; TUMORS; VIRUSES;

GENE THERAPY;

CASPASE 8; GANCICLOVIR; POLYACRYLAMIDE; PROTEIN KINASE C ALPHA; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; GENE CONTROL; GENE DELIVERY SYSTEM; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CASPASE 8; CELL LINE, TUMOR; DNA; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS; PHOSPHORYLATION; POLYMERS; PROTEIN KINASE C-ALPHA; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION;

EID: 78649529322     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.08.017     Document Type: Article

References (29)

1. Schlessinger J., Lemmon M.A. Nuclear signaling by receptor tyrosine kinases: the first robin of spring. Cell 2006, 127:45-48.
2. Normanno N., De Luca A., Bianco C. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366:2-16.
3. Engelman J.A. Targeting PI3K signaling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 2009, 9:550-562.
4. Hofmann J. Protein kinase C isozymes as potential targets for anticancer therapy. Curr. Cancer Drug Targets 2004, 4:125-146.
5. Mackay H.J., Twelves C.J. Targeting the protein kinase C family: are we there yet?. Nat. Rev. Cancer 2007, 7:554-562.
6. O'Brian C.A., Chu F., Bornmann W.G., Maxwell D.S. Protein kinase Cα and e{open} small-molecule targeted therapeutics: a new roadmap to two holy grails in drug discovery?. Expert Rev. Anticancer Ther. 2006, 6:175-186.
7. Kang J.H., Asai D., Kim J.H., Mori T., Toita R., Tomiyama T., Asami Y., Oishi J., Sato Y.T., Niidome T., Jun B., Nakashima H., Katayama Y. Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Cα activation in cancer cells. J. Am. Chem. Soc. 2008, 130:14906-14907.
8. Tomiyama T., Kang J.H., Toita R., Niidome T., Katayama Y. Protein kinase Cα polymeric carrier: its application for gene delivery into human cancers. Cancer Sci. 2009, 100:1532-1536.
9. Toita R., Kang J.H., Kim J.H., Tomiyama T., Mori T., Niidome T., Jun B., Katayama Y. Protein kinase Cα-specific peptide substrate graft-type copolymer for cancer cell-specific gene regulation systems. J. Control. Release 2009, 139:133-139.
10. Kang J.H., Asai D., Yamada S., Toita R., Oishi J., Mori T., Niidome T., Katayama Y. A short peptide is a protein kinase C (PKC)α-specific substrate. Proteomics 2008, 8:2006-2011.
11. Herr I., Debatin K.M. Cellular stress response and apoptosis in cancer therapy. Blood 2001, 98:2603-2614.
12. Bao Q., Shi Y. Apotosome: a platform for the activation of initiator caspases. Cell Death Differ. 2007, 14:56-65.
13. Fillat C., Carrió M., Cascante A., Sangro B. Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene/canciclovir system: fifteen years of application. Curr. Gene Ther. 2003, 3:13-26.
14. Sangro B., Qian C., Schmitz V., Prieto J. Gene therapy of hepatocellular carcinoma and gastrointestinal tumors. Ann N.Y. Acad. Sci. 2002, 963:6-12.
15. Faneca H., Faustino A., Pedroso de Lima M.C. Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy medicated by albumin-associated cationic liposomes. J. Control. Release 2008, 126:175-184.
16. LePecq J.B., Paoletti C. A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. J. Mol. Biol. 1967, 27:87-106.
17. Fukushima S., Miyata K., Nishiyama N., Kanayama N., Yamasaki Y., Kataoka K. PEGylated polyplex micelles from triblock catiomers with spatially ordered layering of condensed pDNA and buffering units for enhanced intracellular gene delivery. J. Am. Chem. Soc. 2005, 127:2810-2811.
18. Lyer A.K., Khaled G., Fang J., Maeda H. Exploiting the enhanced permeability retention effect for tumor targeting. Drug Discov. Today 2006, 11:812-818.
19. Maeda H., Fang J., Inutsuka T., Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int. Immunopharmacol. 2003, 3:319-328.
20. Chono S., Li S.D., Conwell C.C., Huang L. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. J. Control. Release 2008, 131:64-69.
21. Hattori Y., Maitani Y. Folate-linked lipid-based nanoparticle for targeted gene delivery. Curr. Drug Deliv. 2005, 2:243-252.
22. Duan Y., Zheng J., Han S., Wu Y., Wang Y., Li D., Kong D., Yu Y. A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy. J. Control. Release 2008, 127:173-179.
23. 2-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo. J. Control. Release 2009, 135:234-241.
24. Katayama Y., Fujii K., Ito E., Skakihara S., Sonoda T., Murata M., Maeda M. Intracellular signal-responsive artificial gene regulation for novel gene delivery. Biomacromolecules 2002, 3:905-909.
25. Oishi J., Kawamura K., Kang J.H., Kodama K., Sonoda T., Murata M., Niidome T., Katayama Y. An intracellular kinase signal-responsible gene-carrier for cell specific gene therapy. J. Control. Release 2006, 110:431-436.
26. Oishi J., Ijuin M., Sonoda T., Kang J.H., Kawamura K., Mori T., Niidome T., Katayama Y. A protein kinase signal-responsive gene carrier modified RGD peptide. Bioorg. Med. Chem. Lett. 2006, 16:5740-5743.
27. Kawamura K., Oishi J., Kang J.H., Kodama K., Sonoda T., Murata M., Niidome T., Katayama Y. Intracellular signal-responsive gene carrier for cell-specific gene expression. Biomacromolecules 2005, 6:908-913.
28. Asai D., Tsuchiya A., Kang J.H., Kawamura K., Oishi J., Mori T., Niidome T., Shoji Y., Nakashima H., Katayama Y. Inflammatory cell-specific transgene expression system responding to Iκ-B kinase beta activation. J. Gene Med. 2009, 11:624-632.
29. Asai D., Kuramoto M., Shoji Y., Kang J.H., Kodama K.B., Kawamura K., Mori T., Miyoshi H., Niidome T., Nakashima H., Katayama Y. Specific transgene expression in HIV-infected cells using protease-cleavable transcription regulator. J. Control. Release 2010, 141:52-61.